November 20, 2018
Fuji Pharma President Eiji Takemasa Fuji Pharma will shore up its biosimilar business in Japan through a license agreement with Iceland-based biopharma Alvotech under which it has obtained exclusive commercialization rights in Japan for six of the Iceland company’s investigational...read more